JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
WisdomTree
WT
$2.96B
| $6.47M | ﹤0.01% |
294,726
+204,407
| +226% | +$4.31M |
|
2127
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
| $6.47M | ﹤0.01% |
136,912
-5,098
| -4% | -$245K |
|
|
CZZ
2128
DELISTED
Cosan Limited
CZZ
| $6.46M | ﹤0.01% |
+1,048,424
| New | +$7.17M |
|
|
HSII
2129
DELISTED
Heidrick & Struggles
HSII
| $6.45M | ﹤0.01% |
247,403
-274
| -0.1% | -$6.85K |
|
2130
iShares MSCI Australia ETF
EWA
$1.39B
| $6.44M | ﹤0.01% |
306,032
+88,813
| +41% | +$2.02M |
|
2131
CALL
ConocoPhillips
COP
$147B
| $6.41M | ﹤0.01% |
104,400
-100
| -0.1% | -$6.52K |
|
2132
AMERISAFE
AMSF
$543M
| $6.39M | ﹤0.01% |
135,727
+35
| +0% | +$1.58K |
|
|
FNBC
2133
DELISTED
First NBC Bank Holding Company
FNBC
| $6.38M | ﹤0.01% |
177,175
-7,500
| -4% | -$262K |
|
|
SKUL
2134
DELISTED
SKULLCANDY INC
SKUL
| $6.36M | ﹤0.01% |
828,577
+10,929
| +1% | +$99.8K |
|
2135
Microchip Technology
MCHP
$40.3B
| $6.36M | ﹤0.01% |
268,054
-32,702
| -11% | -$794K |
|
2136
TriMas Corp
TRS
$1.43B
| $6.34M | ﹤0.01% |
268,876
-155,322
| -37% | -$3.7M |
|
2137
WSFS Financial
WSFS
$4.12B
| $6.34M | ﹤0.01% |
231,708
+2,682
| +1% | +$68.2K |
|
2138
ACI Worldwide
ACIW
$5.83B
| $6.33M | ﹤0.01% |
257,837
+9,810
| +4% | +$231K |
|
2139
PUT
Silicon Laboratories
SLAB
$7.17B
| $6.29M | ﹤0.01% |
+116,500
| New | +$6.23M |
|
2140
Ironwood Pharmaceuticals
IRWD
$696M
| $6.29M | ﹤0.01% |
622,325
-800,879
| -56% | -$9.31M |
|
2141
Tempest Therapeutics
TPST
$13.7M
| $6.28M | ﹤0.01% |
74
-1
| -1% | -$91.6K |
|
2142
Brown & Brown
BRO
$23.6B
| $6.27M | ﹤0.01% |
381,576
+163,732
| +75% | +$2.68M |
|
|
CLC
2143
DELISTED
Clarcor
CLC
| $6.24M | ﹤0.01% |
100,315
-8,112
| -7% | -$516K |
|
|
PSEM
2144
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
| $6.24M | ﹤0.01% |
474,781
-3,000
| -0.6% | -$40.6K |
|
|
INFI
2145
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $6.24M | ﹤0.01% |
569,932
+130,230
| +30% | +$1.67M |
|
2146
Philips
PHG
$25.7B
| $6.24M | ﹤0.01% |
342,267
+3,856
| +1% | +$76.1K |
|
2147
Service Corp International
SCI
$11.7B
| $6.23M | ﹤0.01% |
211,757
+134,757
| +175% | +$3.82M |
|
2148
NN Inc
NNBR
$255M
| $6.22M | ﹤0.01% |
243,699
+7,045
| +3% | +$185K |
|
|
ALJ
2149
DELISTED
Alon USA Energy Inc
ALJ
| $6.22M | ﹤0.01% |
329,087
-179,615
| -35% | -$3.06M |
|
2150
Oil States International
OIS
$489M
| $6.22M | ﹤0.01% |
166,995
+55,461
| +50% | +$2.33M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.